Greenwich LifeSciences Extends Lock-Up Period for Directors, Officers to March 2026

, MT Newswires -  9:14 AM ET 3/27/2025 Company News

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

09:14 AM EDT, 03/27/2025 (MT Newswires) -- Greenwich LifeSciences ( GLSI ) said Thursday that its board of directors has extended the lock-up period for shares owned by its directors, officers, and existing pre-IPO investors.

The biopharmaceutical company said it has extended the lockup until March 31, 2026, or roughly five and a half years after the company's IPO.

Officers, directors, and certain shareholders will be unable to sell their shares during the lock-up period, unless the board modifies it, the company said.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2025 Midnight Trader, Inc. All rights reserved.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.